文献

J-GLOBAL ID：201402224177989964   整理番号：14A0166786

マウスにおいて,リン酸輸送体の阻害は,窒素含有ビスホスホネート,ゾレドロネートの炎症性および壊死性副作用を改善する

Inhibition of Phosphate Transporters Ameliorates the Inflammatory and Necrotic Side Effects of the Nitrogen-Containing Bisphosphonate Zoledronate in Mice

著者 (12件)： OKADA Satoru (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.) ,  OKADA Satoru (Div. of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku Univ.) ,  KIYAMA Tomomi (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.) ,  KIYAMA Tomomi (Div. of Advanced Prosthetic Dentistry, Graduate School of Dentistry, Tohoku Univ.) ,  SATO Eri (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.) ,  TANAKA Yukinori (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.) ,  OIZUMI Takefumi (Div. of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku Univ.) ,  KUROISHI Toshinobu (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.) ,  TAKAHASHI Tetsu (Div. of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku Univ.) ,  SASAKI Keiichi (Div. of Advanced Prosthetic Dentistry, Graduate School of Dentistry, Tohoku Univ.) ,  SUGAWARA Shunji (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.) ,  ENDO Yasuo (Div. of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku Univ.)
資料名： Tohoku Journal of Experimental Medicine  (Tohoku Journal of Experimental Medicine)
巻： 231  号： 2  ページ： 145-158 (J-STAGE)  発行年： 2013年 
JST資料番号： G0649A  ISSN： 0040-8727  CODEN： TJEMAO  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ビスホスホネート(BP)はピロリン酸類似体である。これらは,...

シソーラス用語： マウス ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0166786&from=J-GLOBAL&jstjournalNo=G0649A") }}

分類 (1件)： その他の代謝作用薬の基礎研究  (GW13060I)

物質索引 (1件)： ゾレドロン酸

引用文献 (52件)：

• Adami, S. & Zamberlan, N. (1996) Adverse effects of bisphosphonate. A comparative review. <i>Drug Saf.</i>, 14, 158-170.
• Anastasilakis, A.D., Goulis, D.G., Kita, M. & Avramidis, A. (2007) Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. <i>Hormones (Athens)</i>, 6, 233-341.
• Anderson, C.M.H. & Thwaites, D.T. (2011) Hijacking solute carriers for proton-coupled drug transport. <i>Physiology</i>, 25, 364-377.
• Buxton, I.L.O. (2006) Pharmakokinetics and pharmacodynamics: the dynamics of drug absorption, distribution, action, and elimination. In <i>Goodman and Gilman’s the pharmacological basis of therapeutics</i>, 11^th edition, edited by Brunton, L.L., Lazo, J.S. & Parker, K.L. McGraw-Hill, New York, NY, pp. 1-39.
• Chrisp, P. & Clissold, S.P. (1991) Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. <i>Drugs</i>, 41, 104-129.

タイトルに関連する用語 (8件)： マウス ,  リン酸輸送体 ,  阻害 ,  窒素 ,  ビスホスホネート ,  炎症 ,  壊死 ,  副作用